WO2004069247A1 - Topical immunotherapy and compositions for use therein - Google Patents
Topical immunotherapy and compositions for use therein Download PDFInfo
- Publication number
- WO2004069247A1 WO2004069247A1 PCT/GB2004/000474 GB2004000474W WO2004069247A1 WO 2004069247 A1 WO2004069247 A1 WO 2004069247A1 GB 2004000474 W GB2004000474 W GB 2004000474W WO 2004069247 A1 WO2004069247 A1 WO 2004069247A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- scalp
- composition
- oil
- immunosuppressant
- hair
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04708815A EP1603560A1 (en) | 2003-02-06 | 2004-02-06 | Topical immunotherapy and compositions for use therein |
AU2004210201A AU2004210201B2 (en) | 2003-02-06 | 2004-02-06 | Topical immunotherapy and compositions for use therein |
US10/544,724 US7517519B2 (en) | 2003-02-06 | 2004-02-06 | Topical immunotherapy and compositions for use therein |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN170MU2003 | 2003-02-06 | ||
IN170/MUM/2003 | 2003-02-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004069247A1 true WO2004069247A1 (en) | 2004-08-19 |
Family
ID=32843826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2004/000474 WO2004069247A1 (en) | 2003-02-06 | 2004-02-06 | Topical immunotherapy and compositions for use therein |
Country Status (4)
Country | Link |
---|---|
US (1) | US7517519B2 (en) |
EP (1) | EP1603560A1 (en) |
AU (1) | AU2004210201B2 (en) |
WO (1) | WO2004069247A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007037665A1 (en) * | 2005-09-28 | 2007-04-05 | Fernando Ahumada Ayala | Preparation for the treatment of inflammatory skin diseases, containing tacrolimus |
WO2012119059A1 (en) * | 2011-03-03 | 2012-09-07 | Allergan, Inc. | Non-aqueous silicone-based ophthalmic formulations |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
MXPA05004278A (en) | 2002-10-25 | 2005-10-05 | Foamix Ltd | Cosmetic and pharmaceutical foam. |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
US7575739B2 (en) | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2010041141A2 (en) | 2008-10-07 | 2010-04-15 | Foamix Ltd. | Oil-based foamable carriers and formulations |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
EP2242476A2 (en) | 2008-01-14 | 2010-10-27 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
MX359879B (en) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Topical tetracycline compositions. |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US8174881B2 (en) | 2009-11-24 | 2012-05-08 | Micron Technology, Inc. | Techniques for reducing disturbance in a semiconductor device |
US8754024B1 (en) * | 2013-02-26 | 2014-06-17 | Michael Scott Fishman | Liquefied-gas aerosol dusting composition containing sucrose octaacetate |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544391A1 (en) * | 1991-09-02 | 1993-06-02 | Teva Pharmaceutical Industries, Ltd. | Compositions for topical treatment of psoriasis and atopic dermatitis |
GB2316074A (en) * | 1996-08-06 | 1998-02-18 | Merck & Co Inc | Macrolides having immunosuppressive activity |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH677448A5 (en) * | 1987-11-09 | 1991-05-31 | Sandoz Ag | |
US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
KR0159766B1 (en) * | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | Hair revitalizing agent |
DE4322826A1 (en) | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmaceutical preparation |
US5635161A (en) * | 1995-06-07 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing vegetable oils |
US6184248B1 (en) | 1996-09-05 | 2001-02-06 | Robert K. K. Lee | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
US6043224A (en) | 1996-09-05 | 2000-03-28 | The Massachusetts Institute Of Technology | Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
WO1999051215A2 (en) | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
US6489335B2 (en) * | 2000-02-18 | 2002-12-03 | Gholam A. Peyman | Treatment of ocular disease |
CN1127955C (en) | 2000-07-07 | 2003-11-19 | 中山医科大学中山眼科中心 | Medicine for treating immune relative disease of anterior chamber and surface of eye |
-
2004
- 2004-02-06 EP EP04708815A patent/EP1603560A1/en not_active Ceased
- 2004-02-06 US US10/544,724 patent/US7517519B2/en active Active
- 2004-02-06 AU AU2004210201A patent/AU2004210201B2/en not_active Ceased
- 2004-02-06 WO PCT/GB2004/000474 patent/WO2004069247A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0544391A1 (en) * | 1991-09-02 | 1993-06-02 | Teva Pharmaceutical Industries, Ltd. | Compositions for topical treatment of psoriasis and atopic dermatitis |
GB2316074A (en) * | 1996-08-06 | 1998-02-18 | Merck & Co Inc | Macrolides having immunosuppressive activity |
Non-Patent Citations (1)
Title |
---|
See also references of EP1603560A1 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007037665A1 (en) * | 2005-09-28 | 2007-04-05 | Fernando Ahumada Ayala | Preparation for the treatment of inflammatory skin diseases, containing tacrolimus |
WO2012119059A1 (en) * | 2011-03-03 | 2012-09-07 | Allergan, Inc. | Non-aqueous silicone-based ophthalmic formulations |
WO2012119070A3 (en) * | 2011-03-03 | 2012-12-06 | Allergan, Inc. | Silicone-based ophthalmic formulations |
CN103491945A (en) * | 2011-03-03 | 2014-01-01 | 阿勒根公司 | Non-aqueous silicone-based ophthalmic formulations |
Also Published As
Publication number | Publication date |
---|---|
AU2004210201B2 (en) | 2009-10-08 |
US7517519B2 (en) | 2009-04-14 |
US20060204446A1 (en) | 2006-09-14 |
EP1603560A1 (en) | 2005-12-14 |
AU2004210201A2 (en) | 2004-08-19 |
AU2004210201A1 (en) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2004210201B2 (en) | Topical immunotherapy and compositions for use therein | |
WO1996000058A1 (en) | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants | |
AU2010305404B2 (en) | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug | |
RU2283098C2 (en) | Coenzyme q-containing cutaneous compositions as active component | |
JPH11511484A (en) | Pharmaceutical composition comprising macrolide or cyclosporin and polyethoxylated hydroxylated fatty acid | |
KR102386585B1 (en) | Topical Compositions Comprising Tacrolimus | |
WO1992011860A1 (en) | Topical formulation of cyclosporine | |
JP2004346085A (en) | Ophthalmic composition containing cyclosporin | |
JP2006522059A (en) | Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases | |
JP2002500200A (en) | Topical ophthalmic remedies including immunosuppressants | |
WO1989010114A1 (en) | Composition for promoting hair growth in androgenetic alopecia and method thereof | |
AU2004212264B9 (en) | Pharmaceutical patch | |
JP5646477B2 (en) | A composition for treating rosacea disease comprising chitosan and dicarboxylic acid | |
WO2004071510A1 (en) | Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis | |
WO2002098463A1 (en) | Antifungal compositions | |
KR20130056825A (en) | Composition for preventing or treating or improvingatopic dermatitis comprising immunosuppressant and transglutaminase 2 inhibitor | |
CN112804985A (en) | Composition for inhibiting cortisone reductase | |
CN112912056A (en) | Composition for inhibiting mineralocorticoid receptor activity | |
MICHALSKA et al. | in the topical treatment of inflammatory dermatoses | |
WO2004069223A2 (en) | Pharmaceutical compositions comprising immunosuppressants and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004210201 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 948/MUMNP/2005 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2004210201 Country of ref document: AU Date of ref document: 20040206 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004708815 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004210201 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10544724 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2004708815 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 06048225 Country of ref document: CO |
|
WWP | Wipo information: published in national office |
Ref document number: 10544724 Country of ref document: US |